Skip to main content
Erschienen in: Annals of Nuclear Medicine 1/2021

08.10.2020 | Original Article

Effects of feeding condition on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice

verfasst von: Kazuaki Yamasaki, Songji Zhao, Mie Nishimura, Yoichi Shimizu, Nagara Tamaki, Hiroshi Takeda, Yuji Kuge

Erschienen in: Annals of Nuclear Medicine | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

123I-15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid ([123I]BMIPP), a fatty acid analog, is widely used for the diagnosis of cardiac diseases. Feeding condition is one of the important factors in the myocardial fatty acid uptake, which may also affect myocardial accumulation of [123I]BMIPP and image quality of [123I]BMIPP scintigraphy. However, the relationship between the myocardial accumulation of [123I]BMIPP and the feeding condition is not entirely clear. Therefore, we determined the myocardial accumulation of [125I]BMIPP in mice at various metabolic statuses induced by fasting in comparison with the hepatic accumulation.

Methods

Fed or fasted (6-, 12-, and 24-h fasted) mice were intravenously injected with [125I]BMIPP (35.2–75.0 kBq, 4 nmol). Radioactivities in the heart and liver were measured at 1, 5, 10, 30, 60, and 120 min after the injection (n = 5–15/time point for each group), and then, the heart-to-liver (H/L) ratios were calculated.

Results

The myocardial accumulation level of [125I]BMIPP in the fed group was almost the same as that in the 6-h-fasted group at each time point, although it was decreased by 12- and 24-h fasting. The H/L ratios of [125I]BMIPP accumulation level were significantly decreased by fasting (1.92 ± 0.22, 1.45 ± 0.13, 1.12 ± 0.13, and 0.91 ± 0.15 at 10 min, and 3.30 ± 0.62, 2.09 ± 0.35, 1.79 ± 0.34, and 1.27 ± 0.06 at 30 min after the injection, respectively, for the fed group and the 6-, 12-, and 24-h-fasted groups; p < 0.0001), largely owing to the increase in the hepatic accumulation level in the fasting groups.

Conclusion

Although short-period (6 h) fasting did not affect the myocardial accumulation level of [125I]BMIPP, the hepatic accumulation level was increased. The present results indicate that the fed condition may provide higher-contrast images in myocardial [123I]BMIPP scintigraphy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol. 2011;18:135–43.CrossRef Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol. 2011;18:135–43.CrossRef
2.
Zurück zum Zitat Hosokawa R, Nohara R, Fujibayashi Y, et al. Myocardial metabolism of 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease. J Nucl Med. 1999;40:471–8.PubMed Hosokawa R, Nohara R, Fujibayashi Y, et al. Myocardial metabolism of 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease. J Nucl Med. 1999;40:471–8.PubMed
3.
Zurück zum Zitat Lopaschuk GD, Ussher JR, Folmes CD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207–58.CrossRef Lopaschuk GD, Ussher JR, Folmes CD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207–58.CrossRef
4.
Zurück zum Zitat Neeley JR, Rovetto MJ, Oram MJ. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972;15:289–329.CrossRef Neeley JR, Rovetto MJ, Oram MJ. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972;15:289–329.CrossRef
5.
Zurück zum Zitat De Geeter F, Caveliers V, Pansar I, et al. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. J Nucl Med. 1998;39:1850–6.PubMed De Geeter F, Caveliers V, Pansar I, et al. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. J Nucl Med. 1998;39:1850–6.PubMed
7.
Zurück zum Zitat Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093–129.CrossRef Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093–129.CrossRef
8.
Zurück zum Zitat van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45:279–93.CrossRef van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45:279–93.CrossRef
9.
Zurück zum Zitat Kurata C, Wakabayashi Y, Shouda S, et al. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP. J Nucl Med. 1997;38:1079–84.PubMed Kurata C, Wakabayashi Y, Shouda S, et al. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP. J Nucl Med. 1997;38:1079–84.PubMed
10.
Zurück zum Zitat Nohara R, Hosokawa R, Hirai T, et al. Effect of metabolic substrate on BMIPP metabolism in canine myocardium. J Nucl Med. 1998;39:1132–7.PubMed Nohara R, Hosokawa R, Hirai T, et al. Effect of metabolic substrate on BMIPP metabolism in canine myocardium. J Nucl Med. 1998;39:1132–7.PubMed
11.
Zurück zum Zitat Dole VP. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956;35:150–4.CrossRef Dole VP. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956;35:150–4.CrossRef
12.
Zurück zum Zitat Torizuka K, Yonekura Y, Nishimura T, et al. The phase 1 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid (123I-BMIPP). Jpn J Nucl Med. 1991;28:681–90. Torizuka K, Yonekura Y, Nishimura T, et al. The phase 1 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid (123I-BMIPP). Jpn J Nucl Med. 1991;28:681–90.
13.
Zurück zum Zitat Akashi Y, Kida K, Suzuki K, et al. The significance of 123I-BMIPP delayed scintigraphic imaging in cardiac patients. Int J Cardiol. 2007;117:145–51.CrossRef Akashi Y, Kida K, Suzuki K, et al. The significance of 123I-BMIPP delayed scintigraphic imaging in cardiac patients. Int J Cardiol. 2007;117:145–51.CrossRef
14.
Zurück zum Zitat Kida K, Akashi Y, Yoneyama K, et al. 123I-BMIPP delayed scintigraphic imaging in patients with chronic heart failure. Ann Nucl Med. 2008;22:769–75.CrossRef Kida K, Akashi Y, Yoneyama K, et al. 123I-BMIPP delayed scintigraphic imaging in patients with chronic heart failure. Ann Nucl Med. 2008;22:769–75.CrossRef
15.
Zurück zum Zitat North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;13:1097–108.CrossRef North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;13:1097–108.CrossRef
Metadaten
Titel
Effects of feeding condition on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice
verfasst von
Kazuaki Yamasaki
Songji Zhao
Mie Nishimura
Yoichi Shimizu
Nagara Tamaki
Hiroshi Takeda
Yuji Kuge
Publikationsdatum
08.10.2020
Verlag
Springer Singapore
Erschienen in
Annals of Nuclear Medicine / Ausgabe 1/2021
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-020-01535-x

Weitere Artikel der Ausgabe 1/2021

Annals of Nuclear Medicine 1/2021 Zur Ausgabe